Radeas LLC Agrees to Pay $11.6 Million to Resolve Allegations of Fraudulent Billing
BOSTON – A North Carolina-based clinical laboratory, Radeas LLC, has agreed to pay $11.6 million to resolve allegations that it submitted false claims for payment to Medicare for medically unnecessary urine drug testing (UDT).
Action Details
- Date:March 31, 2022
- Agency:U.S. Attorney’s Office, District of Massachusetts
-
Enforcement Types:
- Criminal and Civil Actions
.png){kind=logo}